FindMyRecallSubscribe
Class I: serious health riskTerminated

Acella Pharmaceuticals NP Thyroid 60 Recall

NP Thyroid 60, Thyroid Tablets, USP, 1 grain (60 mg), 100-count bottles, Rx Only, Manuf…

Acella Pharmaceuticals, LLC · Alpharetta, GA

Risk level
Class I
Reported by FDA
Jun 10, 2020
Recall ID
D-1299-2020
Check your lot numberHow we source this data

Summary

Acella Pharmaceuticals recalled NP Thyroid 60 starting May 22, 2020. The FDA classified it as Class I (serious health risk) and published enforcement report D-1299-2020 on Jun 10, 2020. Reason: Superpotent Drug. Status: Terminated.

Why it was recalled

Superpotent Drug.

Product description

NP Thyroid 60, Thyroid Tablets, USP, 1 grain (60 mg), 100-count bottles, Rx Only, Manufactured For: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-330-01.

Lot numbers, UPCs & expiration codes

Lots: M330J18-2A, M330J18-3 Exp. AUG-2020

Where it was sold

Distributed Nationwide in the US and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1299-2020
Classification
Class I
Status
Terminated
Recall initiated
May 22, 2020
FDA report date
Jun 10, 2020
Quantity
29,304 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Acella Pharmaceuticals, LLC

Original FDA data

Every field from FDA enforcement report D-1299-2020, exactly as published.

Show all FDA fields
City
Alpharetta
State
GA
Status
Terminated
Country
United States
Event ID
85721
Address
1880 Mcfarland Pkwy Ste 110-B
Code information
Lots: M330J18-2A, M330J18-3 Exp. AUG-2020
Postal code
30005
Report date
Jun 10, 2020
Product type
Drugs
Recall number
D-1299-2020
Classification
Class I
Recalling firm
Acella Pharmaceuticals, LLC
Product quantity
29,304 bottles
Termination date
Jan 19, 2022
Reason for recall
Superpotent Drug.
Voluntary / mandated
Voluntary: Firm initiated
Product description
NP Thyroid 60, Thyroid Tablets, USP, 1 grain (60 mg), 100-count bottles, Rx Only, Manufactured For: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-330-01.
Distribution pattern
Distributed Nationwide in the US and Puerto Rico
Recall initiation date
May 22, 2020
Initial firm notification
Press Release
Center classification date
Jun 8, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1299-2020, published Jun 10, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls